AI Assistant
Blog
Pricing
Log In
Sign Up
758 A phase 1 dose escalation and expansion study of the anti-CD200R1 antibody 23ME-00610 in patients with advanced solid malignancies
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
